Does Dr. KASARA AL HELOU have financial conflicts of interest?

Dr. KASARA AL HELOU (PA) has received a total of $985 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $985 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. KASARA AL HELOU?

According to CMS Open Payments data, Dr. KASARA AL HELOU received funding from OTSUKA AMERICA PHARMACEUTICAL ($317), ALKERMES ($179), and VANDA PHARMACEUTICALS ($176).

Does Dr. KASARA AL HELOU receive research grants or speaking fees?

Dr. KASARA AL HELOU has received $985 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. KASARA AL HELOU

PAReal-Time Hydrated

Specialty: Physician Assistant

Practice Location: SAVANNAH, GA 31406

NPI Number: 1770235855

LIFETIME INDUSTRY VALUE

$985

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AL HELOU is a verified Physician Assistant practitioner based in SAVANNAH, GA.

Between 2021 and 2025, Dr. AL HELOU had an overall industry promotional and research financial footprint of $985 as recorded in the federal CMS Open Payments database.

$985 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AL HELOU's primary funding source is OTSUKA AMERICA PHARMACEUTICAL, which accounts for $317 (representing 32.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

OTSUKA AMERICA PHARMACEUTICAL

Rank 1

$317

32.2%

ALKERMES

Rank 2

$179

18.2%

VANDA PHARMACEUTICALS

Rank 3

$176

17.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.